Terms ending in 2039
Every in-force patent on Actuate Corporation's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,407,759 | Solid Forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione In force · Medium confidence | Actuate Therapeutics Inc. | In force | Medium confidence | |
| US 12,741,973 | Solid Forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione In force · High confidence | Actuate Therapeutics, Inc. | In force | High confidence | |
| US 11,055,308 | Systems and Methods for Integrated Dynamic Runtime Etl Tool and Scalable Analytics Server Platform In force · High confidence | Open Text Inc. | In force | High confidence | |
| US 11,510,904 | Methods of Treating Malignant Lymphoproliferative Disorders In force · High confidence | Actuate Therapeutics Inc. | In force | High confidence | |
| US 11,980,607 | Methods of Treating Malignant Lymphoproliferative Disorders In force · High confidence | Actuate Therapeutics Inc. | In force | High confidence | |
| US 12,145,943 | Solid Forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione In force · Medium confidence | Actuate Therapeutics Inc. | In force | Medium confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Actuate Corporation.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.